Medicine for treating liver cancer, and preparation method and application thereof

A technology for treating liver cancer and drugs, applied in the field of medicine, can solve the problems of insignificant curative effect, large side effects, high cost, etc., and achieve the effects of remarkable curative effect, low production cost and prolonging survival period.

Inactive Publication Date: 2017-05-31
ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

my country mainly relies on surgery, radiotherapy and chemotherapy in the treatment of liver cancer. However, while the above methods kill cancer cells, normal cells of the human body are also damaged. Western medicines with anti-cancer effects have large s

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] In an embodiment of the present invention, a drug for treating liver cancer is composed of the following raw materials in parts by weight: 13 parts of astragalus, 15 parts of chlorogenic acid, 1 part of carvone, and 7 parts of artemisinin.

[0019] Mix astragalus and artemisinin, add deionized water with 5.8 times the mass of the two, and conduct ultrasonic treatment at a temperature of 48° C. for 22 minutes with an ultrasonic power of 900 W to prepare a mixture A. Chlorogenic acid was mixed with mixture A, and subjected to microwave treatment for 8 minutes at a microwave power of 800W to prepare mixture B. Mix carvylone with mixture B, ultrasonicate at a temperature of 55°C for 15 minutes with an ultrasonic power of 700W, and stir at 60°C until dry to obtain the drug.

Embodiment 2

[0021] In an embodiment of the present invention, a drug for treating liver cancer is composed of the following raw materials in parts by weight: 21 parts of astragalus, 25 parts of chlorogenic acid, 5 parts of carvone, and 15 parts of artemisinin.

[0022] Mix astragalus and artemisinin, add deionized water with 5.8 times the mass of the two, and conduct ultrasonic treatment at a temperature of 48° C. for 22 minutes with an ultrasonic power of 900 W to prepare a mixture A. Chlorogenic acid was mixed with mixture A, and subjected to microwave treatment for 8 minutes at a microwave power of 800W to prepare mixture B. Mix carvylone with mixture B, ultrasonicate at a temperature of 55°C for 15 minutes with an ultrasonic power of 700W, and stir at 60°C until dry to obtain the drug.

Embodiment 3

[0024] In an embodiment of the present invention, a drug for treating liver cancer is composed of the following raw materials in parts by weight: 15 parts of astragalus, 18 parts of chlorogenic acid, 2 parts of carvone, and 9 parts of artemisinin.

[0025] Mix astragalus and artemisinin, add deionized water with 5.8 times the mass of the two, and conduct ultrasonic treatment at a temperature of 48° C. for 22 minutes with an ultrasonic power of 900 W to prepare a mixture A. Chlorogenic acid was mixed with mixture A, and subjected to microwave treatment for 8 minutes at a microwave power of 800W to prepare mixture B. Mix carvylone with mixture B, ultrasonicate at a temperature of 55°C for 15 minutes with an ultrasonic power of 700W, and stir at 60°C until dry to obtain the drug.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating liver cancer, and a preparation method and application thereof. The medicine is prepared from the following raw materials in parts by weight: 13 to 21 parts of radix astragali seu hedysari, 15 to 25 parts of chlorogenic acid, 1 to 5 parts of carvone, and 7 to 15 parts of artemisinin. The preparation method comprises the steps of mixing the radix astragali seu hedysari and the artemisinin, adding deionized water with the mass being 5.8 times of the total mass of the radix astragali seu hedysari and the artemisinin, and carrying out ultrasonic treatment for 22 min at the temperature of 48 DEG C to prepare a mixture A; mixing the chlorogenic acid and the mixture A, and carrying out ultrasonic treatment for 8min to prepare a mixture B; mixing the carvone and the mixture B, carrying out ultrasonic treatment for 15min at the temperature of 55 DEG C, and stirring at the temperature of 60 DEG C until dry so as to obtain the medicine. The medicine provided by the invention is simple in preparation process, simple and easy to get the adopted raw materials, low in production cost, simple to take, and good in absorption effect without side effect, the survival time is prolonged, and the patient tolerance is good.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating liver cancer and its preparation method and application. Background technique [0002] Liver cancer is a malignant tumor of the liver, which can be divided into two categories: primary and secondary. Primary malignant tumors of the liver originate from the epithelial or mesenchymal tissues of the liver. The former is called primary liver cancer, which is a malignant tumor with a high incidence in my country and is extremely harmful; rare. Liver cancer seriously threatens people's health and life, and is called "the king of cancer". The 5-year survival rate of patients with intermediate-stage liver cancer is less than 5%. Primary liver cancer mainly includes different pathological types such as hepatocellular carcinoma (HCC, accounting for more than 90%), intrahepatic cholangiocarcinoma (ICC) and mixed hepatocellular carcinoma-intrahepatic cholangiocarci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/481A61P35/00A61K31/216A61K31/122A61K31/366
CPCA61K36/481A61K31/122A61K31/216A61K31/366A61K2236/331
Inventor 不公告发明人
Owner ZHENGZHOU ZHANGMENG NETWORK TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap